| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |